CRWG:NASDAQLeverage Shares 2X Long CRWV Daily ETF Analysis

The ETF launched on March 10, 2026, aiming to deliver 2× daily exposure to CRWV. It currently trades at $2.62, below its 20‑day SMA of $2.66 and far under its 50‑day ($3.64) and 200‑day ($6.51) averages, indicating a bearish momentum. RSI sits at 44, suggesting neither overbought nor oversold conditions, while the MACD shows a bullish signal despite a negative line, hinting at a tentative short‑term reversal. Volatility is extreme at nearly 199% over the past 30 days and beta is a staggering 6.36, underscoring the fund’s sensitivity to market swings. The ETF’s max drawdown of –88% and a support level near $2.09 further highlight the downside risk. Yet, the Fear & Greed Index reads “Greed” (72.43), reflecting broader market optimism that could fuel short‑term rallies.
Despite stable trading volume (~19 M shares daily) and a modest expense ratio of 0.77%, the leveraged structure imposes inherent decay, making the fund unsuitable for holding beyond a single day. The absence of tracking error in the data does not mitigate the compounding risk inherent in 2× daily products. With a narrow price corridor between $2.09 support and $3.22 resistance, any breach of support could trigger sharp declines, while the high expense and volatility erode long‑term returns. Consequently, investors should treat CRWG as a high‑risk, short‑duration tactical tool rather than a core holding.